Symrise AG

SY1: XETR (DEU)
View Stock Summary
Morningstar Rating for StocksFair ValueEconomic MoatCapital Allocation
#>fLOCK|?w?LOCK|NzY#<<&

Symrise Earnings: Organic Sales Growth Slows, and Further Normalization Expected in 2025

Symrise delivered fourth-quarter organic sales growth of 0.9%, or 5.9% excluding the hyperinflation-related pricing adjustment. EBITDA margin was up 160 basis points to 20.7%, supported by operating leverage and cost-saving initiatives.

Sponsor Center